Strategic Considerations for Bridging Drug Delivery Devices: PBBM-Enabled Assessment of Formulation/Device Changes

Authors: Suarez-Sharp S
Conference: ACCP
Outline
  • Typical Phases of Drug Development and When Device Bridging Considerations Arise
  • Possible Approaches to Reducing Regulatory Burden and Complexity
    • Concept of PBBM-Safe Space
      • Data Needed to Build a PBBM
      • Role of PBBM in Device/Formulation Bridging Across Product Lifecycle
  • Case Studies for Formulation and Device Bridging
  • Key Take Aways

By Sandra Suarez-Sharp

ACCP 2026 Annual Meeting, September 27-29, 2026, North Bethesda, Maryland